Your search returned 39 studies. (Get alerts for new studies):
- Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
9 Locations available
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck - Basaloid Squamous Cell Carcinoma - Undifferentiated Carcinoma - Adenosquamous Cell Carcinoma
1 Location available
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell
1 Location available
- Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma - Head and Neck Cancer
1 Location available
- A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
Conditions: Head and Neck Cancer
1 Location available
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - R
1 Location available
- Phase II Study of RAD001 Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer - Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Conditions: Carcinoma, Squamous Cell of the Head and Neck
25 Locations available
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
Conditions: Upper Aerodigestive Tract Lesions - Neoplasms, Oropharyngeal - Oropharyngeal Cancer - Neoplasms, Hypopharyngeal - Hypopharyngeal Cancer - Head and Neck Neoplasms - UADT Neoplasms - Carcinoma, Squamous Cell - Papilloma
1 Location available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
Conditions: Squamous Cell Carcinoma of the Head and Neck - Human Papilloma Virus
1 Location available
- A Phase II Study of RT Concurrent With Cetuximab in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Do Not Qualify For Standa
Conditions: Squamous Cell Carcinoma of the Larynx, Hypopharynx, Oropharynx, or Oral Cavity. - The Patients Will be Limited to Age 70 and Older, - OR w/ Co-morbidities Precluding Treatment With Chemotherapy
1 Location available
- Phase 1 and 2 Study of PX-866 and Cetuximab
Conditions: Incurable Metastatic Colorectal Carcinoma - Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
31 Locations available
- Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Lymphoepithelioma of the Nasopharynx - Recurrent Lymphoepithelioma of the Oropharynx - Recurrent Mucoepidermoid Carcinoma of the Oral Cavity - Recurrent Squamous Cell Carcinoma of the Hypop
1 Location available
- A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
1 Location available
- Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Conditions: Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
5 Locations available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Stereotactic Body Radiotherapy for Head and Neck Tumors
Conditions: Squamous Cell Carcinoma of the Head and Neck - Nasopharyngeal Carcinoma - Salivary Gland Cancer - Head and Neck Sarcoma - Paraganglioma of Head and Neck - Chordoma of Head and Neck - Chondrosarcoma of Head and Neck - Angiofibroma of Head and Neck
1 Location available
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer - Oropharyngeal Cancer - Human Papillomavirus - Squamous Cell Cancer
1 Location available
- Cabazitaxel - PF Induction Chemotherapy
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Conditions: Squamous Cell Carcinoma of the Head and Neck
2 Locations available
- Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Study of ACE-041 in Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
2 Locations available
- Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Mucoepidermoid Carcinoma of the Oral Cavity - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurrent Squamous Cell Carcinoma of t
1 Location available
- Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma Of The Head And Neck
1 Location available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell - Head and Neck Neoplasms - Oropharyngeal Neoplasms
1 Location available
- Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
2 Locations available
- Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin - Stage I Squamous Cell Carcinoma of the Hypopharynx - Stage I Squamous Cell Carcinoma of the Larynx - Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage I Squamous Cell Carcinoma of the Oropharynx - Sta
1 Location available
|